2294 Growth modulation index (GMI) to assess salvage chemotherapy benefit after FOLFIRINOX progression in metastatic pancreatic adenocarcinoma
Ducoulombier, A., Quintin, J., Desjardin, M., Hautefeuille, V., Desauw, C., Parzy, A., Bouche, O., Chauffert, B., Clisant, S., El Hajbi, F., Becouarn, Y., Bennouna, J., Hebbar, M., Penel, N., Adenis,Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31210-2
Date:
September, 2015
File:
PDF, 60 KB
english, 2015